More powerful, lasting pain relief vs. methylprednisolone acetate (MPA) in a level I study.8
- DUROLANE is as effective as MPA at 6 weeks for WOMAC† Pain responder rate.8
- MPA reached maximum effect on mean WOMAC† Pain scores at 6 weeks.8
- Results trended in favour of DUROLANE for WOMAC† Pain, Physical Function and
Stiffness from 12-26 weeks.8
†WOMAC Pain responder rate was defined as a relative improvement from baseline in WOMAC Pain score of at least 40%, and an absolute improvement of at least five points.
WOMAC Pain scores (± 95% CIs) following double-blind treatment with either DUROLANE or MPA.
*Significant improvement from baseline with DUROLANE vs. MPA at week 26 (p=0.034).
MPA: methylprednisolone acetate
